ATYR PHARMA INC's ticker is LIFE and the CUSIP is 002120103. A total of 45 filers reported holding ATYR PHARMA INC in Q2 2015. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $521,000 | -71.8% | 572,489 | -18.0% | 0.01% | -66.7% |
| Q1 2018 | $1,850,000 | -25.0% | 698,234 | -0.9% | 0.02% | -25.0% |
| Q4 2017 | $2,466,000 | -35.3% | 704,524 | -6.6% | 0.02% | -28.6% |
| Q3 2017 | $3,810,000 | +33.5% | 754,524 | -10.1% | 0.03% | +16.7% |
| Q2 2017 | $2,853,000 | +0.7% | 839,264 | +3.7% | 0.02% | +4.3% |
| Q1 2017 | $2,834,000 | +23.0% | 809,642 | -24.5% | 0.02% | +21.1% |
| Q4 2016 | $2,305,000 | -30.3% | 1,072,108 | +3.1% | 0.02% | -38.7% |
| Q3 2016 | $3,308,000 | +25.2% | 1,040,135 | +9.4% | 0.03% | +24.0% |
| Q2 2016 | $2,642,000 | +36.6% | 950,461 | +93.7% | 0.02% | +38.9% |
| Q1 2016 | $1,934,000 | -36.3% | 490,750 | +58.8% | 0.02% | -43.8% |
| Q4 2015 | $3,038,000 | +60.7% | 309,062 | +67.8% | 0.03% | +45.5% |
| Q3 2015 | $1,890,000 | -32.1% | 184,177 | +22.6% | 0.02% | +37.5% |
| Q2 2015 | $2,782,000 | – | 150,240 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Polaris Venture Management Co. V, L.L.C. | 1,827,992 | $18,755,000 | 12.78% |
| EcoR1 Capital, LLC | 840,462 | $8,623,000 | 3.92% |
| Rock Springs Capital Management LP | 388,996 | $3,991,000 | 0.32% |
| SPHERA FUNDS MANAGEMENT LTD. | 209,027 | $2,145,000 | 0.27% |
| Baker Brothers Advisors | 2,335,125 | $23,958,000 | 0.22% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 461,530 | $4,735,000 | 0.18% |
| TIVERTON ASSET MANAGEMENT LLC | 472,236 | $4,845,000 | 0.11% |
| RS INVESTMENT MANAGEMENT CO LLC | 1,082,249 | $11,104,000 | 0.10% |
| RIVERHEAD CAPITAL MANAGEMENT LLC | 415,377 | $4,262,000 | 0.07% |
| Magnetar Financial LLC | 354,659 | $3,639,000 | 0.05% |